Preventing Relapse to Smoking Among Prisoners After Release

NCT ID: NCT04271371

Last Updated: 2024-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-08

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prisoners experience huge health inequalities, and their exceptionally high smoking prevalence (five times the national average) contributes significantly to their high mortality. Since the introduction of smoke-free polices across Her Majesty's Prison and Probation Service (HMPPS) in England and Wales, prisoners are now obliged to abstain from smoking while held in prison. This represents a unique opportunity to promote lifelong cessation in this highly disadvantaged and marginalised group. However, evidence suggests most prisoners intend to resume smoking as soon as possible after release. A systematic review of prison smoke-free polices worldwide concluded that there was a need for new research to identify effective strategies to reduce relapse in these individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study will be to develop and pilot test the feasibility and acceptability of an intervention to help prevent prisoners relapse to smoking after release. The study will work in accordance with the Medical Research Council (MRC) framework for developing and evaluating complex interventions. The Preventing Relapse tO Smoking among PrisonErs after Release (PROSPER) study consists of three key Phases:

1. Document the support provided to manage nicotine addiction during imprisonment and in the periods immediately before and after release; establish the extent to which prisoners intentionally resume or unintentionally relapse to smoking after release; and obtain views on how relapse might be prevented.
2. Drawing on current literature and findings from Phase 1, develop and design an prototype intervention to prevent smoking relapse after release.
3. To pilot the designed prototype intervention and conduct a process evaluation to inform the development of further work in this area.

The research will be carried out in three prisons in the East Midlands. The main duties will include recruitment of participants (HMPPS staff members and prisoners), data collection, data analysis, assist with intervention development and refining related intervention materials/resources, co-facilitate Patient and Public Involvement (PPI) groups, contribute to the ethical application for the pilot intervention, and preparation of manuscripts for peer-review publication.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Smoking Reduction Electronic Cigarette Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prototype intervention

To be developed through Phase 1 and 2

Not yet developed

Intervention Type OTHER

A prototype intervention will be developed over Phase 1 \& 2 and piloted in Phase 3 of this study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Not yet developed

A prototype intervention will be developed over Phase 1 \& 2 and piloted in Phase 3 of this study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All participants are aged 18 or over (no upper age limit)
* Are currently residing in one of the three study sites (HMPs Nottingham, Ranby and Sudbury)
* Male (women will not be held at any of the study sites)
* Have a provisional release date within the next 2 months.
* Are capable of understanding and consenting to the study.
* Remand and sentenced prisoners.
* Who report that they are a current smoker and/or a current smoker prior to entering prison (smoked up to 7 days before entering prison), and/or were in prison (and still on the same sentence) and a current smoker prior to the smoke-free prison policy.

3\. Reception prisoner cross-sectional
* All participants are aged 18 or over (no upper age limit)
* Are currently residing in the open prison study site (HMP Sudbury)
* Male (women will not be held at any of the study sites)
* Have been in the open prison more than two weeks but for less than 3 months.
* Have been transferred from a closed prison.
* Are capable of understanding and consenting to the study.
* Sentenced prisoners.
* Who report that they were a current smoker prior to entering prison (smoked up to 7 days before entering prison), and/or were in prison (and still on the same sentence) and a current smoker prior to the smoke-free prison policy.

Exclusion Criteria

* Present a serious risk of harm to the researchers, highlighted in PNOMIS records or by a member of staff.
* Non-smokers.
* Being deported post release.
* Been in prison for less than four weeks.

3\. Reception prisoner cross-sectional
* Present a serious risk of harm to the researchers, highlighted in PNOMIS records or by a member of staff.
* Been in prison for less than 2 weeks.
* Non-smokers.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Her Majesty's Prison and Probation Service (HMPPS)

UNKNOWN

Sponsor Role collaborator

Public Health England

OTHER_GOV

Sponsor Role collaborator

Cancer Research UK

OTHER

Sponsor Role collaborator

Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)

UNKNOWN

Sponsor Role collaborator

University of Nottingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Nottingham, School of Medicine

Nottingham, Please Select, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

254028

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Staff Stop Smoking Project
NCT04263545 COMPLETED NA
Mobile Contingency Management for Smoking Cessation
NCT04881630 ACTIVE_NOT_RECRUITING NA
Smartphone Based Smoking Cessation Intervention
NCT03740490 COMPLETED PHASE2/PHASE3